Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Reichert

Showing results (31-40 of 437) with videos related to

Pageof 44
Sort By:
Mabs|January 13, 2010
Letter from the editorJanice M Reichert
Current Pharmaceutical Biotechnology|December 17, 2008
Monoclonal antibodies as innovative therapeuticsJanice M Reichert
Mabs|June 4, 2013
Antibodies to watch in 2013: Mid-year updateJanice M Reichert
Mabs|November 6, 2010
Antibody-based therapeutics to watch in 2011Janice M Reichert
Mabs|April 14, 2011
Next generation and biosimilar monoclonal antibodies: essential considerations towards regulatory acceptance in Europe. February 3-4, 2011, Freiburg, GermanyJanice M Reichert
Mabs|April 26, 2012
Marketed therapeutic antibodies compendiumJanice M Reichert
Mabs|December 21, 2012
Which are the antibodies to watch in 2013?Janice M Reichert
Trends in Biotechnology|August 16, 2000
New biopharmaceuticals in the USA: trends in development and marketing approvals 1995-1999J M Reichert
Nature Biotechnology|September 5, 2001
Monoclonal antibodies in the clinicJ M Reichert
Nature Reviews. Drug Discovery|September 3, 2003
Trends in development and approval times for new therapeutics in the United StatesJanice M Reichert
Pageof 44

Showing results (31-40 of 437) with videos related to

Sort By:
Pageof 44
Mabs|January 13, 2010
Letter from the editorJanice M Reichert
Current Pharmaceutical Biotechnology|December 17, 2008
Monoclonal antibodies as innovative therapeuticsJanice M Reichert
Mabs|June 4, 2013
Antibodies to watch in 2013: Mid-year updateJanice M Reichert
Mabs|November 6, 2010
Antibody-based therapeutics to watch in 2011Janice M Reichert
Mabs|April 14, 2011
Next generation and biosimilar monoclonal antibodies: essential considerations towards regulatory acceptance in Europe. February 3-4, 2011, Freiburg, GermanyJanice M Reichert
Mabs|April 26, 2012
Marketed therapeutic antibodies compendiumJanice M Reichert
Mabs|December 21, 2012
Which are the antibodies to watch in 2013?Janice M Reichert
Trends in Biotechnology|August 16, 2000
New biopharmaceuticals in the USA: trends in development and marketing approvals 1995-1999J M Reichert
Nature Biotechnology|September 5, 2001
Monoclonal antibodies in the clinicJ M Reichert
Nature Reviews. Drug Discovery|September 3, 2003
Trends in development and approval times for new therapeutics in the United StatesJanice M Reichert
Pageof 44